Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice

European Journal of Pain

Volumn 13, Issue 7, 2009, Pages 691-703

  Popp, Laura ^a   Häussler, Annett ^a   Olliges, Anke ^a   Nüsing, Rolf ^a   Narumiya, Shuh ^b   Geisslinger, Gerd ^a   Tegeder, Irmgard ^a  

^a Institut fur Klinische Pharmakologie   (Germany)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Knockout mice; Pain; Prostaglandin receptor; Sensitization; Spinal cord

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FORMALDEHYDE; PROSTACYCLIN; PROSTAGLANDIN D; PROSTAGLANDIN E; PROSTAGLANDIN F; PROTEIN C FOS; THROMBOXANE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; IMMUNOREACTIVITY; KNOCKOUT MOUSE; LICKING; MALE; MECHANICAL STIMULATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SPINAL CORD DORSAL HORN; THERMAL STIMULATION;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORMALDEHYDE; HOT TEMPERATURE; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, EPOPROSTENOL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; RECEPTORS, PROSTAGLANDIN E; RECEPTORS, THROMBOXANE;

EID: 67649321795     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.09.001     Document Type: Article

References (67)

1. 2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci 5 (2002) 34-40
2. Baba H., Kohno T., Moore K.A., and Woolf C.J. Direct activation of rat spinal dorsal horn neurons by prostaglandin E2. J Neurosci 21 (2001) 1750-1756
3. Ballou L.R., Botting R.M., Goorha S., Zhang J., and Vane J.R. Nociception in cyclooxygenase isozyme-deficient mice. Proc Natl Acad Sci USA 97 (2000) 10272-10276
4. Bar K.J., Natura G., Telleria-Diaz A., Teschner P., Vogel R., Vasquez E., et al. Changes in the effect of spinal prostaglandin E2 during inflammation: prostaglandin E (EP1-EP4) receptors in spinal nociceptive processing of input from the normal or inflamed knee joint. J Neurosci 24 (2004) 642-651
5. Beiche F., Klein T., Nusing R., Neuhuber W., and Goppelt-Struebe M. Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J Neuroimmunol 89 (1998) 26-34
6. Bilak M., Wu L., Wang Q., Haughey N., Conant K., St Hillaire C., et al. PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 56 (2004) 240-248
7. Broom D.C., Samad T.A., Kohno T., Tegeder I., Geisslinger G., and Woolf C.J. Cyclooxygenase 2 expression in the spared nerve injury model of neuropathic pain. Neuroscience 124 (2004) 891-900
8. Christensen A.P., and Corey D.P. TRP channels in mechanosensation: direct or indirect activation?. Nat Rev Neurosci 8 (2007) 510-521
9. Echeverria V., Clerman A., and Dore S. Stimulation of PGE receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following beta-amyloid exposure. Eur J Neurosci 22 (2005) 2199-2206
10. Geisslinger G., Muth-Selbach U., Coste O., Vetter G., Schrodter A., Schaible H.G., et al. Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study. J Neurochem 74 (2000) 2094-2100
11. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., and Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
12. 2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells. J Cell Physiol 207 (2006) 261-270
13. Hasegawa H., Katoh H., Yamaguchi Y., Nakamura K., Futakawa S., and Negishi M. Different membrane targeting of prostaglandin EP3 receptor isoforms dependent on their carboxy-terminal tail structures. FEBS Lett 473 (2000) 76-80
14. Hizaki H., Segi E., Sugimoto Y., Hirose M., Saji T., Ushikubi F., et al. Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP2. Proc Natl Acad Sci USA 96 (1999) 10501-10506
15. Hosl K., Reinold H., Harvey R.J., Muller U., Narumiya S., and Zeilhofer H.U. Spinal prostaglandin E receptors of the EP2 subtype and the glycine receptor alpha3 subunit, which mediate central inflammatory hyperalgesia, do not contribute to pain after peripheral nerve injury or formalin injection. Pain 126 (2006) 46-53
16. Hosoi M., Oka T., and Hori T. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats. Pain 71 (1997) 303-311
17. Kawahara H., Sakamoto A., Takeda S., Onodera H., Imaki J., and Ogawa R. A prostaglandin E2 receptor subtype EP1 receptor antagonist (ONO-8711) reduces hyperalgesia, allodynia, and c-fos gene expression in rats with chronic nerve constriction. Anesth Analg 93 (2001) 1012-1017
18. Kawamura T., Yamauchi T., Koyama M., Maruyama T., Akira T., and Nakamura N. Expression of prostaglandin EP2 receptor mRNA in the rat spinal cord. Life Sci 61 (1997) 2111-2116
19. Koppert W., Wehrfritz A., Korber N., Sittl R., Albrecht S., Schuttler J., et al. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 108 (2004) 148-153
20. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
21. Liang X., Wu L., Hand T., and Andreasson K. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. J Neurochem 92 (2005) 477-486
22. Lin C.R., Amaya F., Barrett L., Wang H., Takada J., Samad T.A., et al. Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity. J Pharmacol Exp Ther 319 (2006) 1096-1103
23. Maihofner C., Tegeder I., Euchenhofer C., deWitt D., Brune K., Bang R., et al. Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience 101 (2000) 1093-1108
24. Malmberg A.B., and Yaksh T.L. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 263 (1992) 136-146
25. Malmberg A.B., and Yaksh T.L. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci 15 (1995) 2768-2776
26. 2 EP2 receptor in cerebral ischemia. J Neurosci 24 (2004) 257-268
27. McNamara C.R., Mandel-Brehm J., Bautista D.M., Siemens J., Deranian K.L., Zhao M., et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 104 (2007) 13525-13530
28. Mebane H., Turnbach M.E., and Randich A. Spinal EP receptors mediating prostaglandin E2-induced mechanical hyperalgesia, thermal hyperalgesia, and touch-evoked allodynia in rats. J Pain 4 (2003) 392-399
29. Minami T., Matsumura S., Mabuchi T., Kobayashi T., Sugimoto Y., Ushikubi F., et al. Functional evidence for interaction between prostaglandin EP3 and kappa-opioid receptor pathways in tactile pain induced by human immunodeficiency virus type-1 (HIV-1) glycoprotein gp120. Neuropharmacology 45 (2003) 96-105
30. 2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 133 (2001) 438-444
31. Minami T., Nishihara I., Sakamoto K., Ito S., Hyodo M., and Hayaishi O. Blockade by ONO-NT-012, a unique prostanoid analogue, of prostaglandin E2-induced allodynia in conscious mice. Br J Pharmacol 115 (1995) 73-76
32. Minami T., Nishihara I., Uda R., Ito S., Hyodo M., and Hayaishi O. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Br J Pharmacol 112 (1994) 735-740
33. 2 inhibits prostaglandin E2-induced allodynia in conscious mice. J Pharmacol Exp Ther 278 (1996) 1146-1152
34. Minami T., Okuda-Ashitaka E., Nishizawa M., Mori H., and Ito S. Inhibition of nociceptin-induced allodynia in conscious mice by prostaglandin D2. Br J Pharmacol 122 (1997) 605-610
35. Minami T., Uda R., Horiguchi S., Ito S., Hyodo M., and Hayaishi O. Allodynia evoked by intrathecal administration of prostaglandin F2 alpha to conscious mice. Pain 50 (1992) 223-229
36. Minami T., Uda R., Horiguchi S., Ito S., Hyodo M., and Hayaishi O. Allodynia evoked by intrathecal administration of prostaglandin E2 to conscious mice. Pain 57 (1994) 217-223
37. Moriyama T., Higashi T., Togashi K., Iida T., Segi E., Sugimoto Y., et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 1 (2005) 3
38. Murata T., Ushikubi F., Matsuoka T., Hirata M., Yamasaki A., Sugimoto Y., et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388 (1997) 678-682
39. Muth-Selbach U.S., Tegeder I., Brune K., and Geisslinger G. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology 91 (1999) 231-239
40. Nakao K., Murase A., Ohshiro H., Okumura T., Taniguchi K., Murata Y., et al. CJ-023, 423, a novel, potent and selective prostaglandin EP4 receptor antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 322 (2007) 686-694
41. Nakayama Y., Omote K., Kawamata T., and Namiki A. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn. Brain Res 1010 (2004) 62-68
42. Nakayama Y., Omote K., and Namiki A. Role of prostaglandin receptor EP1 in the spinal dorsal horn in carrageenan-induced inflammatory pain. Anesthesiology 97 (2002) 1254-1262
43. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365 (1993) 166-170
44. Nusing R.M., Treude A., Weissenberger C., Jensen B., Bek M., Wagner C., et al. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome. J Am Soc Nephrol 16 (2005) 2354-2362
45. 2 as a major nociceptive mediator in acetic acid-induced writhing reaction: a study using IP-receptor disrupted mice. Adv Exp Med Biol 469 (1999) 265-268
46. Oka T., Aou S., and Hori T. Intracerebroventricular injection of prostaglandin E2 induces thermal hyperalgesia in rats: the possible involvement of EP3 receptors. Brain Res 663 (1994) 287-292
47. Oka T., Hori T., Hosoi M., Oka K., Abe M., and Kubo C. Biphasic modulation in the trigeminal nociceptive neuronal responses by the intracerebroventricular prostaglandin E2 may be mediated through different EP receptors subtypes in rats. Brain Res 771 (1997) 278-284
48. Okuda-Ashitaka E., Minami T., Matsumura S., Takeshima H., Reinscheid R.K., Civelli O., et al. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury. Eur J Neurosci 23 (2006) 995-1004
49. Oliva P., Berrino L., de Novellis V., Palazzo E., Marabese I., Siniscalco D., et al. Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia. Eur J Pharmacol 530 (2006) 40-47
50. Omote K., Kawamata T., Nakayama Y., Yamamoto H., Kawamata M., and Namiki A. Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model. Anesthesiology 97 (2002) 170-176
51. Omote K., Yamamoto H., Kawamata T., Nakayama Y., and Namiki A. The effects of intrathecal administration of an antagonist for prostaglandin E receptor subtype EP1 on mechanical and thermal hyperalgesia in a rat model of postoperative pain. Anesth Analg 95 (2002) 1708-1712 table of contents
52. Pulichino A.M., Rowland S., Wu T., Clark P., Xu D., Mathieu M.C., et al. Prostacyclin antagonism reduces pain and inflammation in rodent models of hyperalgesia and chronic arthritis. J Pharmacol Exp Ther 319 (2006) 1043-1050
53. Qu W.M., Huang Z.L., Xu X.H., Aritake K., Eguchi N., Nambu F., et al. Lipocalin-type prostaglandin D synthase produces prostaglandin D2 involved in regulation of physiological sleep. Proc Natl Acad Sci USA 103 (2006) 17949-17954
54. Sarkar S., Hobson A.R., Hughes A., Growcott J., Woolf C.J., Thompson D.G., et al. The prostaglandin E2 receptor-1 (EP1) mediates acid-induced visceral pain hypersensitivity in humans. Gastroenterology 124 (2003) 18-25
55. Segi E., Sugimoto Y., Yamasaki A., Aze Y., Oida H., Nishimura T., et al. Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice. Biochem Biophys Res Commun 246 (1998) 7-12
56. Smith W.L., Marnett L.J., and DeWitt D.L. Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 49 (1991) 153-179
57. Southall M.D., and Vasko M.R. Prostaglandin receptor subtypes, EP3C and EP4, mediate the prostaglandin E2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276 (2001) 16083-16091
58. Stock J.L., Shinjo K., Burkhardt J., Roach M., Taniguchi K., Ishikawa T., et al. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 107 (2001) 325-331
59. Takasaki I., Nojima H., Shiraki K., Sugimoto Y., Ichikawa A., Ushikubi F., et al. Involvement of cyclooxygenase-2 and EP3 prostaglandin receptor in acute herpetic but not postherpetic pain in mice. Neuropharmacology 49 (2005) 283-292
60. Takayama K., Yuhki K., Ono K., Fujino T., Hara A., Yamada T., et al. Thromboxane A2 and prostaglandin F2 alpha mediate inflammatory tachycardia. Nat Med 11 (2005) 562-566
61. Tegeder I., Niederberger E., Vetter G., Brautigam L., and Geisslinger G. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E2 release in the spinal cord. J Neurochem 79 (2001) 777-786
62. Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 395 (1998) 281-284
63. Watanabe K., Kawamori T., Nakatsugi S., Ohta T., Ohuchida S., Yamamoto H., et al. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res 59 (1999) 5093-5096
64. Wilson S.J., Dowling J.K., Zhao L., Carnish E., and Smyth E.M. Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler Thromb Vasc Biol 27 (2007) 290-296
65. Yaksh T.L., Hua X.Y., Kalcheva I., Nozaki-Taguchi N., and Marsala M. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci USA 96 (1999) 7680-7686
66. Yamada T., Fujino T., Yuhki K., Hara A., Karibe H., Takahata O., et al. Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase. Circulation 108 (2003) 2381-2386
67. Zhao P., Waxman S.G., and Hains B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci 27 (2007) 2357-2368